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miR-15a/16 reduces retinal leukostasis
through decreased pro-inflammatory
signaling
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Abstract
Background: Hyperglycemia is a significant risk factor for diabetic retinopathy and induces increased inflammatory
responses and retinal leukostasis, as well as vascular damage. Although there is an increasing amount of evidence
that miRNA may be involved in the regulation in the pathology of diabetic retinopathy, the mechanisms by which
miRNA mediate cellular responses to control onset and progression of diabetic retinopathy are still unclear. The
purpose of our study was to investigate the hypothesis that miR-15a/16 inhibit pro-inflammatory signaling to
reduce retinal leukostasis.
Methods: We generated conditional knockout mice in which miR-15a/16 are eliminated in vascular endothelial
cells. For the in vitro work, human retinal endothelial cells (REC) were cultured in normal (5 mM) glucose or
transferred to high glucose medium (25 mM) for 3 days. Transfection was performed on REC in high glucose
with miRNA mimic (hsa-miR-15a-5p, hsa-miR-16-5p). Statistical analyses were done using unpaired Student t test
with two-tailed p value. p < 0.05 was considered significant. Data are presented as mean ± SEM.
Results: We demonstrated that high glucose conditions decreased expression of miR-15a/16 in cultured REC.
Overexpression of miR-15a/16 with the mimic significantly decreased pro-inflammatory signaling of IL-1β, TNFα,
and NF-κB in REC. In vivo data demonstrated that the loss of miR-15a/16 in vascular cells led to increased retinal
leukostasis and CD45 levels, together with upregulated levels of IL-1β, TNFα, and NF-κB.
Conclusions: The data indicate that miR-15a/16 play significant roles in reducing retinal leukostasis, potentially
through inhibition of inflammatory cellular signaling. Therefore, we suggest that miR-15a/16 offer a novel potential
target for the inhibition of inflammatory mediators in diabetic retinopathy.
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Background
Hyperglycemia and diabetes have clear influences on the
dysfunction of vascular endothelial cells, leukocyte adhe-
sion, and inflammatory signaling [1–3]. However, the
molecular and physiological mechanisms of diabetes-
induced retinal damage are still not clear. Over the last
decade, the role of microRNA (miRNA) as a mediator of
pathological mechanisms in diabetic retinopathy has
come to light. miRNA (miR) are small non-coding RNA
molecules and post-transcriptional regulators, leading to
reduced expression of target mRNAs. Based on current
findings, the human genome encodes at least 1000
microRNAs [4] and approximately 30 to 60% of human
genes are estimated to be regulated by miRNAs [5, 6].
miR-15a may be a key miRNA in the diabetic retina,
as lower levels of miR-15a were found in the plasma of
patients with prevalent diabetes mellitus (DM) [7]. In
addition, miR-15a levels were decreased in high glucose
conditions in human umbilical vein endothelial cells
(HUVEC) [8]. Our previous study showed altered ex-
pression of miR-15 family members, miR-15b and miR-
16, in retinal endothelial cells (REC) cultured in high
glucose conditions [9]. In contrast, elevated levels of
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hsa-miR-15a were found in eyes with proliferative dia-
betic retinopathy (PDR) [10]. Also, it was reported that
miR-15a was highly expressed in early endothelial pro-
genitor cells [11].
REC are substantially affected in diabetic retinopathy.
Our previous studies have shown regulatory effects of
miRNA on insulin resistance [9] and inflammatory sig-
naling [12] in human REC cultured under high glucose
conditions. The pathology of diabetic retinopathy in-
volves endothelial dysfunction, as well as activation of
inflammatory signaling and leukocyte adhesion. Retinal
leukostasis, a histological indication of retinal inflamma-
tion, can be induced by vascular endothelial growth fac-
tor (VEGF) [13, 14], which is a direct target of miR-15a
in HUVEC [15]. In addition to retinal leukostasis, work
has shown that diabetic retinas have elevated levels of
inflammatory cytokines, such as TNFα and IL-1β [16].
Both TNFα and IL-1β levels can be regulated through
toll-like receptor (TLR) signaling, which is reduced by
miR-15a/16 in LPS-treated macrophages [17]. In addition
to VEGF, pro-inflammatory signaling molecules (TLR5/8,
IRAK1, TRAF6) are predicted targets of miR-15a (targets-
can.org). NF-κB activation through TLR5 [18, 19] and
TLR8 [20] has been shown in HEK 293 cells.
Thus, we aimed to investigate the hypothesis that
miR-15a/16 inhibit the pro-inflammatory signaling of
TNFα, IL-1β, and NF-κB to reduce retinal leukostasis.
To perform this study, we utilized REC in normal and
high glucose conditions for in vitro work and miR-15a/
16-conditional knockout mice for in vivo analysis.
Methods
Cell culture
Human REC were acquired from Cell Systems Corpor-
ation (CSC, Kirkland, WA). Cells were grown in M131
medium containing microvascular growth supplement
(Invitrogen), 10 μg/ml gentamycin, and 0.25 μg/ml
amphotericin B. For experiments, cells were maintained
in normal (5 mM) glucose or transferred to high glucose
medium (25 mM) (Cell Systems) for 3 days. Only pri-
mary cells within passage 5 were used. Cells were
quiesced by incubating in high or normal glucose
medium without growth supplementation for 20 h and
used to perform the experiments.
Cell transfection with microRNA-mimics
REC were transfected with miRNA mimic (hsa-miR-15a-
5p and hsa-miR-16-5p) (Invitrogen, Carlsbad, CA) using
Oligofectamine (Invitrogen) following manufacturer in-
structions. miR-transfection was performed 48 h before
cell harvest. A final concentration of 30 nM was used
when transfected separately (miR-15a and miR-16), and
15 nM was used in combination (miR-15a + miR-16).
Additionally, a 30-nM Mimic Negative Control (Invitrogen)
was transfected into REC cultured in high glucose as
a control. Other control groups, normal glucose (NG)
and high glucose (HG), were treated with Oligofecta-
mine only. The levels of miRNA overexpression were
verified using quantitative reverse transcription poly-
merase chain reaction and real-time PCR.
Real-time quantitative PCR
Total RNA was isolated and purified using the TRIzol
method, and the purity and quantity of RNA were mea-
sured using Synergy HTX multi-mode reader (BioTek;
Winooski, VT). For polyA tailing reverse-transcriptase
PCR, 5 μg of total RNA was treated with DNase I for
15 min at room temperature (Promega; Madison, WI)
and then added with polyA using (polyA) polymerase
(NEB; Ipswich, MA) at 37 °C for 1 h. The final reaction
mixtures were extracted with phenol/chloroform, pre-
cipitated with isopropanol, and redissolved in 25 μl
diethylpyrocarbonate (DEPC)-treated water. PolyA-tailed
RNA (6 μl) was reverse-transcribed into first-strand
cDNA using SuperScript II reverse transcriptase (Invi-
trogen) with the oligo-dT adapter primer 5′GCGAGCA
CAGAATTAATACGACTCACTATAGGTTTTTTTTTT
TTVN3′. For PCR, 1 μl of RT product was diluted three
times and used as a template in each reaction. The re-
verse primer was from the adapter sequence 5′
GCGAGCACAGAATTAATACGACTCAC3′ and the
forward primers were specific to miR-15a and miR-16
mature sequences. U6 small non-coding RNA sequence
was amplified as the internal control using the primers
5′GCTTGCTTCGGCAGCACATATAC (forward) and
5′TGCATGTCATCCTTGCTCAGGG3′ (reverse). The
SYBR-Green-based real-time PCR was performed using
the CFX Connect PCR system (BioRad; Hercules, CA).
The relative expression of miRNA was calculated based
on the formula 2(−delta delta Ct). Delta-delta Ct values are
delta Ct exp. − delta Ct cont..
Generation of miR-15a/16 Cre-LoxP mice
miR-15a/16 floxed mice (B6-129S-mirc30.tm1.1rdf/J)
and B6.FVB-Tg (cdh5-cre)7Mlia/J Cre mice were pur-
chased from Jackson Laboratories. The miR-15a/16
floxed mice were crossed with cdh5-Cre mice to gen-
erate conditional knockout mice in which miR-15a/16
is eliminated in vascular endothelial cells. At 3 months
of age, both male and female mice from miR-15a/16
floxed and miR-15a/16 Cre-LoxP groups were used
for further analyses. All animal procedures were
reviewed and approved by the Institute Animal Care
and Use Committees of the Wayne State University
School of Medicine (Protocol # A 11-08-14) and con-
form to NIH guidelines.
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Genotyping analysis
Genomic DNA from the ear punch of 2-week-old mice
was digested with one-step tail DNA extract buffer
(100 mM Tris, 5 mM EDTA, 200 mM NaCl, 1% Triton)
plus proteinase K (10 mg/ml) at 55 °C overnight and
then heat-inactivated at 85 °C for 45 min. Sequences of
primer pairs used to screen the transgenic mice were as
follows: (1) miR-15a/16- 5′→3′ forward: TCAGTTAAC
CAATAAAAA GGTCAGC, reverse: GCCTGGGTCTC
ACCA TGTAG; (2) Cdh5-cre: forward: AGGCAGCT
CACAAAGGAACAAT, reverse: TCGTTGCATCGACC
GGTAA; (3) Cdh5-cre internal positive forward: CTAG
GCCACAGAATTGAAAGATCT, reverse: GTAGGTG
GAAATTCTAGCATCATCC. Standard PCR reaction
protocol was completed using KAPA2G HotStart Geno-
typing PCR Mix (KK5621, KAPA Biosystems). PCR reac-
tion was performed with the following steps: denature
95 °C 3 min, 35 cycles at 95 °C, 15 s, 60 °C 15 s, 72 °C s/
kb, and then final extension at 72 °C 1 min.
Western blot analysis
After rinsing with cold PBS, REC or whole retinal lysates
were collected in lysis buffer containing protease and
phosphatase inhibitors. Equal amounts of protein were
separated on precast Tris-glycine gels (Invitrogen,
Carlsbad, CA) and then blotted onto a nitrocellulose
membrane. After blocking in TBST (10 mM Tris-HCl
buffer, pH 8.0, 150 mM NaCl, 0.1% Tween 20) and 5%
(w/v) BSA, the membrane was treated with appropriate
primary antibodies followed by incubation with second-
ary antibodies labeled with horseradish peroxidase.
Antigen-antibody complexes were detected by chemillu-
minescence reagent kit (Thermo Scientific, Pittsburgh,
PA). Primary antibodies used were phosphorylated NF-
κB p65 (Ser 536) (Cat.# 3033), NF-κB p65 (Cat.# 4764)
(rabbit monoclonal, 1:500; all purchased from Cell
Signaling, Danvers, MA), and beta actin (Santa Cruz,
Santa Cruz, CA). Imaging was performed using C500
system (Azure Biosystems, Dublin, CA) within a linear
range of exposure. Signal intensity of protein bands was
normalized by beta actin. Even staining of beta actin was
observed after loading of equal amounts of protein.
ELISA analysis
TNFα protein concentrations were measured using a
TNFα ELISA (Thermo Fisher scientific, Pittsburgh, PA).
Into all wells, 100 μg protein was loaded, with analyses
based on a standard curve. A human IL-1β ELISA (R
and D system, Minneapolis, MN) was used to measure
levels of the pro-inflammatory cytokine, IL-1β, in cell ly-
sates. Equal protein was loaded (100 μg) into all wells to
allow for comparisons based on OD. Manufacturer’s in-
structions were followed for all ELISA, except extended
incubation of samples and antibody reagents overnight
at 4 °C.
Leukostasis analysis
To assess leukostasis in the retina, we collected retinas
from five mice each of the Cre-loxP and floxed only ani-
mals. Eye globes were enucleated and placed into 4%
paraformaldehyde for 1 day. After rinsing in PBS, the
retinas were dissected out gently and immunohisto-
chemistry was performed. Briefly, retinas were incubated
in 5% BSA for 2 h, followed by incubation in a cocktail
of primary antibodies CD45 (Cat#. 550586, mouse
monoclonal, 1:100, BD Pharmingen) and isolectin GS-
IB4 conjugated with Alexa Fluo 488 (Cat#. I21411,
1:100, Life technologies) for 2 days at 4 °C. After rinsing
in PBS, the retinas were incubated with goat anti-mouse
Alexa Fluor 555 antibody (Cat# A21424, 1:500, Life
technologies) overnight at 4 °C. The retinas were rinsed
in PBS and flat mounted onto glass slides. Imaging ana-
lysis was performed using confocal microscopy (Leica,
Buffalo Grove, IL).
Flow cytometry analysis
Single-cell suspensions were prepared from neuronal
retinal tissue of the miR-15a/16 floxed, miR-15a/16 cre/
loxP mice by incubating with 0.05% trypsin for 30 min
at 37 °C. The cell suspension was then passed through a
70-μm nylon mesh (Fisher Scientific). Fc (CD16/32) re-
ceptors were blocked with anti-CD16/32 (clone 2.4G2)
antibody prior to cell surface staining. To stain cell sur-
face antigens, all retinal cells were incubated in 100 μl of
staining buffer (1xPBS containing 2% FBS and 0.1% so-
dium azide) at 4 °C for 30 min with PE-Cy7-conjugated
CD45 antibody (clone 30-F11). Peripheral blood and
bone marrow samples were also obtained from both
groups of mice and analyzed for numbers of circulating
leukocytes. Ab-stained cells were analyzed on LSRFor-
tessa flow cytometer (BD Biosciences), and the data was
analyzed with FlowJo 10.1r5 software. All the antibodies
were obtained from BD Biosciences (San Diego, CA).
Statistics
Statistical analyses were done using Prism software
(GraphPad, La Jolla, CA). Analyses were done using
unpaired Student t test with two-tailed p value. p <
0.05 was considered significant. Data are presented as
mean ± SEM. For Western blot data, a representative
blot is presented.
Results
miR-15a expression was decreased in high glucose
conditions in REC
Our previous study demonstrated a 0.2-fold decrease in
miR-16 levels in REC cultured under high glucose
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conditions as compared to normal glucose [9]. In the
present study, we found that high glucose also decreased
the miR-15a expression by 0.4-fold compared to normal
glucose (Fig. 1a).
Since we found that high glucose conditions signifi-
cantly decreased miR-15a and miR-16 expression in
REC, we wanted to elevate the miRNA expression
through transfection with miRNA mimics. The levels of
miR-15a expression were increased 84-fold in REC
treated with mimics compared to cells transfected with
control (Fig. 1b). We previously reported that transfec-
tion with miR-16a mimics increased miR-16a expression
by 54-fold compared to REC in high glucose-treated
with control [9].
miR-15a/16 reduced the levels of IL-1β and TNFα in high
glucose conditions
Elevated levels of inflammatory molecules, including
TNFα and IL-1β, have been shown in diabetic conditions
[16, 21, 22]. Our previous study demonstrated that miR-
15b/16 decreased TNFα levels in REC cultured in high
glucose conditions [9]. In this study, we wanted to
examine whether miR-15a/16 overexpression could de-
crease IL-1β and TNFα levels in REC cultured under
high glucose conditions. We found that high glucose
conditions increased both IL-1β and TNFα levels in
REC. However, overexpression of miR-15a/16 resulted in
significant decreases of the inflammatory signaling in
REC (Fig. 2), suggesting miR-15a/16 plays a role in sup-
pressing pro-inflammatory signaling, specifically IL-1β
and TNFα, in REC under high glucose conditions.
miR-15a/16 suppressed NF-κB activation in high glucose
conditions
Our previous study has shown that the phosphorylation
of NF-κB p65 (Ser 536) was increased in REC exposed
to high glucose [12]. miR-15a is predicted to target
TLR5/and 8, and the TLR signaling mediates the
activation of NF-κB [18–20, 23, 24]. Additionally, TNFα
is known to activate NF-κB [25, 26].
Thus, we investigated whether NF-κB levels in REC
were reduced in high glucose conditions after transfec-
tion with miR-15a/16 mimics. Our results demonstrated
that REC overexpressing miR-15a/16 showed reduced
levels of NF-κB phosphorylation in high glucose condi-
tions (Fig. 3). Therefore, our in vitro study suggests that
miR-15a/16 plays a role in the suppression of pro-
inflammatory signaling in high glucose conditions.
miR-15a/16 inhibited leukostasis in vivo
Our in vitro data suggest that miR-15a/16 play a role in
inhibiting pro-inflammatory signaling in diabetic condi-
tions. Investigating the role of miR-15a/16 in vivo is crit-
ical to confirm protective effects of the miR on the
diabetic retina. To generate conditional knockout mice
in which miR-15a/16 is eliminated in vascular endothe-
lial cells, we crossed miR-15a/16 floxed mice with cdh5-
Cre mice. After two generations, tissues from ear punch
of 2-week-old mice were collected and processed for
genotyping. PCR genotying showed DNA bands from
three different groups of mice: wild-type, heterozygous,
and homozygous mutant. Results demonstrated that mu-
tant mice, miR-15a/16 Cre-LoxP, were positive for Cre
and homozygous for floxed allele (Additional file 1).
We studied whether miR-15a/16 plays a role in redu-
cing leukostasis in the retina. Retinas were isolated from
miR-15a/16 floxed and miR-15a/16 Cre-LoxP mice at
3 months of age. Immunostaining was performed on
whole mount retina to label leukocytes and blood vessels
using antibodies against CD45 and isolectin B4, respect-
ively. We found larger numbers of CD45-labeled
leukocytes in miR-15a/16 Cre-LoxP mice compared to
miR-15a/16 floxed mice (Fig. 4, top panels). Therefore,
our results demonstrated that miR-15a/16 play a role in
reducing retinal leukostasis in vivo. To get a more
quantitative view of whether miR-15a/16 regulate
Fig. 1 Decrease of miR-15a expression in high glucose conditions, and transfection-induced fold changes. a Fold change of miR-15a expression is
shown. After 3 days of REC culture in high glucose (25 mM) medium, miR-15a expression was reduced (0.4-fold reduction) compared to that in
normal glucose (NG; 5 mM) group. b Fold changes of miR-15a/16 after transfection in REC. REC were transfected with mimics (30 nM of final con-
centration) of miR-15a and/or miR-16 in high glucose conditions. Approximately 84- and 114-fold increases of miR-15a levels were detected fol-
lowing transfection with miR-15a and miR-15a/16 mimics, respectively, compared to HG control. *p < 0.05 versus HG, N = 3; data are mean ± SEM
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inflammatory cells, we performed flow cytometry on ret-
inal tissue separated from unmanipulated eyes of miR-
15a/16 Cre-LoxP and miR-15a/16 floxed mice. Retinal
tissues underwent enzymatic digestion to obtain a
single-cell suspension for flow cytometry. As is shown in
Fig. 4 bottom panels, the loss of miR-15a/16 in the ret-
ina led to a significant increase in the frequency and ab-
solute number of CD45+ leukocytes. Collectively, our
results showed a moderate but statistically significant in-
crease in the influx of CD45+ leukocytes in the retinal
tissue lacking miR-15a/16 expression.
Additionally, we determined whether miR-15a/16
Cre-loxP mice have an increased number of circulat-
ing leukocytes compared to control floxed mice. To
assess this, flow cytometry was carried out on the
peripheral blood and bone marrow samples obtained
from control floxed and miR-15a/16 Cre-loxP mice.
Our results showed no significant difference in fre-
quency and absolute number of circulating leukocytes,
when compared between both groups of mice (Fig. 5).
These results clearly indicate that circulating pool of
leukocytes is not accountable for an increased accu-
mulation of CD45+ cells seen in the retinal tissue of
miR-15a/16 Cre-loxP mice.
miR-15a/16 suppressed IL-1β and TNFα signaling in vivo
As we showed inhibitory roles of miR-15a/16 on pro-
inflammatory signaling in cultured REC, we next investi-
gated whether miR-15a/16 has the same effects on the
levels of IL-1β and TNFα in vivo. At 3 months of age,
we collected whole retinas from miR-15a/16 floxed and
Cre-LoxP mice and analyzed the retinal lysates using
ELISA. Our results demonstrated that the levels of IL-1β
and TNFα were significantly increased in the miR-15a/
16 Cre-LoxP mice compared to miR-15a/16 floxed mice
(Fig. 6). Thus, data strongly suggest that miR-15a/16
play a role in the suppression of pro-inflammatory sig-
naling in the retina.
miR-15a/16 inhibits NF-κB activation in vivo
In addition to the inhibitory effects of miR-15a/16 on
the levels of pro-inflammatory cytokines, we also wanted
to confirm the regulatory roles of miR-15a/16 on the
phosphorylation of NF-κB in vivo. NF-kB phosphoryl-
ation was significantly higher in the retina from miR-
15a/16 Cre-LoxP mice compared to miR-15a/16 floxed
mice (Fig. 7). The results indicate that loss of miR-15a/
16 in retinal endothelial cells induces increased levels of
NF-κB phosphorylation. Thus, the outcome suggests
that miR-15a/16 play an important role in reducing ret-
inal leukostasis, through suppressing inflammatory sig-
naling of IL-1β, TNFα, and NF-κB in the retina.
Fig. 2 Assessment of IL-1β and TNFα levels in cultured REC. ELISA results for IL-1β (a) and TNFα (b) on REC in normal glucose (NG, 5 mM) or
high glucose (HG, 25 mM) and transfected groups. miR-15a/16 reduced the levels of both IL-1β and TNFα significantly, compared to control HG
condition. #p < 0.05 versus NG, *p < 0.05 versus HG, $p < 0.05 versus Neg., N = 4; data are mean ± SEM
Fig. 3 Effects of miR-15a/16 on NF-κB (Ser 536) phosphorylation in
vitro. REC were cultured in normal glucose (5 mM, NG) or high glu-
cose (25 mM, HG) and transfected groups. miR-15a/16 decreased the
levels of NF-κB phosphorylation significantly, compared to control
HG condition. #p < 0.05 versus NG, *p < 0.05 versus HG, $p < 0.05 ver-
sus Neg., N = 3; data are mean ± SEM. A representative blot is shown
Ye et al. Journal of Neuroinflammation  (2016) 13:305 Page 5 of 9
Discussion
Diabetic complications in the retina involve many fac-
tors, including activation of pro-inflammatory signaling,
endothelial dysfunction and death, and apoptosis of ret-
inal cells [2, 27, 28]. Yet we have an incomplete under-
standing of the molecular regulators that play a role in
the pathological mechanisms of diabetic retinopathy. In
this study, we focused on miRNA as a mediator of ret-
inal inflammation, as an emerging regulator of signaling
pathways involved in diabetic retinopathy.
Our previous studies and literature implicate the in-
volvement of miR-15a/16 in the pathology of diabetes.
In our studies, we found that REC cultured in high glu-
cose conditions had decreased levels of miR-15a/16. This
is consistent with previous studies showing the reduc-
tion of miR-15a levels in HUVEC cultured under high
glucose conditions [8] and in the plasma of patients with
prevalent DM [7]. However, eyes with PDR showed in-
creased levels of hsa-miR-15a [10], which may reflect a
key characteristic of miRNA, where expression and func-
tion are both cell- and tissue-specific.
Activation of pro-inflammatory signaling is a key fac-
tor that contributes to the pathological responses of dia-
betic retinopathy [3, 28]. miR-15a/16 are inhibitory to
TLR4 inflammatory signaling in mouse macrophages
treated with LPS [17]. Furthermore, we previously had
shown that miR-15b/16 overexpression suppress TNFα
signaling in REC in high glucose conditions [9]. In the
present study, we showed that miR-15a/16 play a signifi-
cant role in the reduction of pro-inflammatory signaling
(IL-1β and TNFα) in vitro, as well as in vivo. TLR path-
ways mediate the activation of NF-κB [18, 23, 24]. NF-
Fig. 4 Effects of miR-15a/16 on retinal leukostasis. Mouse retinas were flat mounted and immunostained with CD45 (leukocytes, red) and isolectin
B4 (blood vessels, green). miR-15a/16 Cre-LoxP mice showed intense leukostasis compared to the miR-15a/16 floxed mice. More CD45-positive
cells were observed in miR-15a/16 Cre-LoxP mice than miR-15a/16 floxed mice, and some of CD45-positive cells were found outside of the vessels
(arrows). N = 5 mice for each group. Representative FACS plots denoting the frequencies of CD45+ leukocytes in retinal tissue. Bar diagrams de-
note the frequencies and number of CD45+ leukocytes. Data were analyzed using two-tailed Student t test (*p < 0.05). Data are mean ± SEM. N =
4 (miR-15a/16 floxed), 3 (miR-15a/16 Cre-LoxP)
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κB is another important signaling molecule that contrib-
utes to inflammation in diabetic retinopathy [29–31].
Our previous study demonstrated that TLR4 and NF-κB
signaling were reduced in REC when miR-146a was
overexpressed in high glucose conditions [12]. In the
current study, we demonstrated that NF-κB activation
was inhibited by miR-15a/16 overexpression in cultured
REC with exposure to high glucose, which was con-
firmed in our miR-15a/16 conditional knockout mice.
Previous studies have shown that hyperglycemia and high
glucose conditions induce leukocyte adhesion to endothe-
lial cells [32, 33]. Work has shown that miR-146a can
Fig. 5 Effects of miR-15a/16 on the number of circulating leukocytes. Flow cytometry analysis was performed using the peripheral blood and
bone marrow samples collected from control floxed and miR-15a/16 Cre-loxP mice. No significant difference was found in the frequency and
absolute number of circulating leukocytes between the two groups of mice. Bar diagrams denote the frequencies and number of CD45+ leuko-
cytes in peripheral blood and bone marrow. Data were analyzed using two-tailed Student t test (ns = non-significant). Data are mean ± SEM. N = 3
(miR-15a/16 floxed), 3 (miR-15a/16 Cre-LoxP)
Fig. 6 Changes of IL-1β and TNFα levels in the retina. ELISA was performed using retinal lysates. Increased levels of IL-1β (a) and TNFα (b) were
found in miR-15a/16 Cre-LoxP mice compared to the miR-15a/16 floxed mice. *P < 0.05 vs floxed. N = 5 for all groups. Data are mean ± SEM
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reduce NF-κB activation, leading to decrease of leukocyte
adhesion to REC [30]. However, little else is reported on
the role of microRNA in retinal leukostasis. From our in
vivo study using miR-15a/16 Cre-loxP mice, we found that
the loss of miR-15a/16 resulted in significant increase of
leukostasis and inflammatory cells in the retina. Our flow
cytometry data of the bone marrow and blood showed a
comparable number of circulating CD45+ cells in both
control floxed and miR-15a/16 Cre-loxP mice. Even though
retinas were not perfused prior to the analysis, our results
suggest that circulating pool of leukocytes is not account-
able for an increased number of CD45+ cells seen in the
retinal tissue of miR-15a/16 Cre-loxP mice. However, the
increased number of CD45+ cells seen in the retinal tissue
could be the combination of leukocytes adhered to retinal
blood vessels and the ones that have come out of the blood
vessels to the retinal tissue. Therefore, our outcomes indi-
cate that miR-15a/16 in REC play a crucial role in the regu-
lation of leukocyte adhesion in vivo. Therefore, this is the
first evidence we are aware of that miR-15a/16 can
regulate retinal leukostasis, potentially by suppressing
pro-inflammatory signaling.
As one potential molecular mechanism of miR-15a/16
regulation of retinal inflammation, altered insulin signaling
could be a candidate. Downstream molecules of the insulin
signaling pathway are predicted targets of miR-15a and
miR-16 (targetscan.org). Increases in leukostasis have been
associated with insulin resistance [34], and our previous
study showed that miR-15b/16 played a role in the
inhibition of insulin resistance via reduced TNFa and
SOCS3 signaling and increased IGFBP-3 levels, resulting in
REC protection from hyperglycemia-induced apoptosis [9].
It is possible that miR-15a and miR-15b exert similar func-
tions as they share the same seed sequence [35], and we will
explore this further in future studies.
Although we have not examined the efficiency of delet-
ing miR-15/16 cluster from the vascular endothelium of
miR-15a/16 Cre-loxP mice, our results from in vivo stud-
ies strongly support successful deletion of the miR-cluster
in the vascular endothelial cells. Wang et al. [36] demon-
strated clear effects of miR-15a on maintaining retinal per-
meability in the retinas of Tie2-miR-15a transgenic mice.
Conclusions
Overall, we showed that high glucose conditions de-
creased expression of miR-15a/16 in REC. In such con-
ditions, overexpression of miR-15a/16 decreased pro-
inflammatory mediators IL-1β, TNFα, and NF-κB in cul-
tured REC. Moreover, we demonstrated the loss of miR-
15a/16 in retinal endothelial cells increased inflamma-
tory signaling of IL-1β, TNFα, NF-κB, and retinal leu-
kostasis in the retina of conditional knockout mice.
Thus, we suggest that miR-15a/16 is a potential target
for the development of therapeutic strategies on diabetic
retinopathy.
Additional file
Additional file 1: Genotyping of representative samples from ten mice.
Tissues were collected from tail at 2 weeks of age. (Top) PCR bands
showing WT, HET, miR-15a/16 Cre-loxP genotypes. (Bottom) PCR bands
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